October 2024 ZOHU Call/Webinar

What to know

A video recording of this webinar is posted below. Visit CDC TRAIN to get free continuing education (CE) for this webinar.

1 hour

Oct 2, 2024

Webinar details

Presentation topics

  • Federal Response to the Emergence of Highly Pathogenic Avian Influenza A H5N1 in Dairy Cattle
  • Overview of CDC's Response to Highly Pathogenic Avian Influenza A (H5N1)
  • HPAI H5N1 in Dairy Cattle: A Novel Challenge to the Milk Safety System

Watch the webinar

Featuring

Eric Deeble, VMD | Presenter
Deputy Under Secretary
Marketing and Regulatory Programs, U.S. Department of Agriculture
Lizette O. Durand, VMD, PhD, DACVPM | Presenter
Chief Veterinary Officer
Influenza Division, U.S. Centers for Disease Control and Prevention
Cindy L. Burnsteel, DVM | Presenter
Deputy Director for Drugs and Devices
Office of Surveillance and Compliance, U.S. Food and Drug Administration

Continuing Education (CE)

Visit CDC Train to receive continuing education (CE).

Web-on-Demand (Recording)

  • Course Name: WD4565(SC)-100224
  • Start Date: November 5, 2024
  • End Date: November 5, 2026

Series objectives

1. Identify an implication for human, animal, and environmental health.

2. Identify a One Health approach strategy for prevention of public health threats.

3. Identify a One Health approach strategy for detection of public health threats.

4. Identify a One Health approach strategy for responding to public health threats.

5. List two ways to improve collaborative practice across the public healthcare team.

Disclosures

In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.

CDC, our planners, and presenters wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept commercial or in-kind support for this activity.